Canandaigua National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
+23,502
New +$1.35M 0.11% 156
2025
Q4
$1.37M Sell
25,448
-4,766
-16% -$229K 0.12% 151
2025
Q3
$1.36M Sell
30,214
-1,529
-5% -$71.4K 0.12% 164
2025
Q2
$1.47M Sell
31,743
-6,151
-16% -$302K 0.14% 146
2025
Q1
$2.31M Sell
37,894
-2,043
-5% -$119K 0.23% 99
2024
Q4
$2.26M Sell
39,937
-2,345
-6% -$131K 0.22% 102
2024
Q3
$2.19M Sell
42,282
-2,952
-7% -$138K 0.21% 112
2024
Q2
$1.88M Sell
45,234
-7,048
-13% -$315K 0.2% 111
2024
Q1
$2.84M Sell
52,282
-3,535
-6% -$180K 0.42% 71
2023
Q4
$2.86M Sell
55,817
-8,998
-14% -$472K 0.44% 64
2023
Q3
$3.76M Buy
64,815
+249
+0.4% +$15.3K 0.61% 42
2023
Q2
$4.13M Sell
64,566
-649
-1% -$43.5K 0.67% 38
2023
Q1
$4.52M Buy
+65,215
New +$4.6M 0.76% 35
2020
Q1
$4.6M Buy
82,503
+4,938
+6% +$302K 0.97% 28
2019
Q4
$4.98M Buy
77,565
+14,264
+23% +$817K 0.84% 33
2019
Q3
$3.21M Buy
63,301
+2,322
+4% +$109K 0.57% 54
2019
Q2
$2.77M Buy
60,979
+3,772
+7% +$176K 0.51% 56
2019
Q1
$2.73M Buy
57,207
+2,868
+5% +$143K 0.52% 55
2018
Q4
$2.83M Sell
54,339
-2,478
-4% -$133K 0.6% 52
2018
Q3
$3.53M Sell
56,817
-716
-1% -$42.5K 0.63% 45
2018
Q2
$3.18M Buy
57,533
+964
+2% +$52.1K 0.61% 46
2018
Q1
$3.58M Buy
56,569
+995
+2% +$64K 0.46% 59
2017
Q4
$3.41M Sell
55,574
-1,505
-3% -$94.1K 0.61% 45
2017
Q3
$3.64M Sell
57,079
-14
-0% -$817 0.69% 41
2017
Q2
$3.18M Sell
57,093
-1,873
-3% -$102K 0.65% 44
2017
Q1
$3.21M Sell
58,966
-2,972
-5% -$163K 0.95% 31
2016
Q4
$3.62M Sell
61,938
-19
-0% -$1.04K 1.09% 26
2016
Q3
$3.34M Sell
61,957
-856
-1% -$55K 0.97% 30
2016
Q2
$4.62M Sell
62,813
-3,819
-6% -$270K 1.31% 22
2016
Q1
$4.26M Buy
66,632
+2,975
+5% +$188K 1.25% 24
2015
Q4
$4.38M Sell
63,657
-290
-0.5% -$19.2K 1.34% 20
2015
Q3
$3.79M Sell
63,947
-1,131
-2% -$71.7K 1.21% 23
2015
Q2
$4.33M Buy
65,078
+2,975
+5% +$196K 1.27% 21
2015
Q1
$4.01M Sell
62,103
-827
-1% -$51.8K 1.2% 24
2014
Q4
$3.71M Sell
62,930
-775
-1% -$43.7K 1.18% 21
2014
Q3
$3.26M Buy
63,705
+1,173
+2% +$58.6K 1.08% 25
2014
Q2
$3.03M Buy
62,532
+168
+0.3% +$8.28K 1.01% 29
2014
Q1
$3.24M Sell
62,364
-4,495
-7% -$239K 1.1% 24
2013
Q4
$3.55M Sell
66,859
-1,485
-2% -$75.6K 1.25% 19
2013
Q3
$3.16M Sell
68,344
-2,330
-3% -$102K 1.2% 20
2013
Q2
$3.16M Buy
+70,674
New +$3.07M 1.24% 21

Other funds holding BMY

Canandaigua National Bank & Trust's BMY Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 23,502 shares worth $1.35M. The stake represents 0.11% of the portfolio and ranks #156 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in BMY as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.98M in Q4 2019. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Canandaigua National Bank & Trust held 23,502 shares of Bristol-Myers Squibb worth $1.35M as of Q2 2026.
  • Bristol-Myers Squibb was a new Canandaigua National Bank & Trust position in Q2 2026.
  • Bristol-Myers Squibb made up 0.11% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #156 holding.
  • Canandaigua National Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
  • Canandaigua National Bank & Trust's Bristol-Myers Squibb position peaked at $4.98M in Q4 2019.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.